Aviva PLC Buys 21,457 Shares of GE HealthCare Technologies Inc. $GEHC

Aviva PLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 340,667 shares of the company’s stock after acquiring an additional 21,457 shares during the period. Aviva PLC owned approximately 0.07% of GE HealthCare Technologies worth $25,233,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Glenview Trust co boosted its stake in GE HealthCare Technologies by 4.4% in the 1st quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after purchasing an additional 139 shares during the period. Silver Oak Securities Incorporated lifted its holdings in shares of GE HealthCare Technologies by 4.6% during the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock worth $236,000 after buying an additional 140 shares in the last quarter. Chicago Capital LLC boosted its position in shares of GE HealthCare Technologies by 2.2% in the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after acquiring an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH grew its stake in shares of GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after acquiring an additional 143 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its position in GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after acquiring an additional 148 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on GEHC. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a report on Wednesday, October 29th. Wells Fargo & Company dropped their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $73.05 on Monday. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a market capitalization of $33.28 billion, a price-to-earnings ratio of 15.09, a price-to-earnings-growth ratio of 2.75 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The company’s 50 day simple moving average is $75.12 and its 200 day simple moving average is $73.56.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the prior year, the company earned $1.14 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.